Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces.

Chronic Dis Can

Surveillance and Risk Assessment Division, Centre for Chronic Disease Prevention and Control, Population and Public Health Branch, Health Canada, Ottawa, Ontario, Canada.

Published: February 2005

Occupational factors have been proposed to play a critical role in bladder cancer. This population-based case-control study was conducted to confirm the association between selected occupational and non-occupational risk factors and risk of bladder cancer using data collected from the four western Canadian provinces. Unconditional logistic regression analyses were based on 549 histologically confirmed bladder cancer cases and 1099 controls. Bladder cancer risk was found to increase with increasing pack-years of cigarette smoking with an odds ratio (OR) in the highest quartile of 3.32 (95% confidence interval [CI], 2.28-4.82). A dose-response relationship was demonstrated between bladder cancer and pack-years of smoking (p < 0.0001). A positive trend was observed with coffee consumption in men (p < 0.0001), with the highest risk in the highest category of exposure: drinkers of four cups or more per day had an OR of 1.77 (95% CI 1.11-2.82). Increased bladder cancer risk was associated with self-reported exposure at work to several chemicals: asbestos (OR 1.69 [95% CI 1.07-2.65]); mineral, cutting or lubricating oil (1.64 [95% CI 1.06-2.55]); benzidine (2.20 [95% CI 1.00-4.87]). The population attributable fraction (PAF) estimates were 51% for cigarette smoking, 17% for heavy coffee consumption, 10% for mineral, cutting or lubricating oil exposure, 6% for asbestos exposure, and 1% for benzidine exposure. Although self-reported chemical exposures have important limitations, the findings are suggestive of increased risk for several associations previously reported between chemical agents or industries and risk of bladder cancer.

Download full-text PDF

Source

Publication Analysis

Top Keywords

bladder cancer
32
cancer risk
12
bladder
8
cancer
8
risk
8
western canadian
8
canadian provinces
8
risk bladder
8
cigarette smoking
8
coffee consumption
8

Similar Publications

: Diabetes mellitus (DM) is associated with worse surgical outcomes, and is a risk factor for bladder cancer and subsequent oncological outcomes. This study evaluated outcomes robot-assisted radical cystectomy (RARC) compared to open radical cystectomy (ORC) in patients with DM. : Data of adults ≥ 18 years old with DM who underwent radical cystectomy were extracted from the United States National Inpatient Sample database 2005-2018.

View Article and Find Full Text PDF

Bladder cancer (BC) is a prevalent urinary malignancy and muscle-invasive bladder cancer (MIBC) is particularly aggressive and associated with poor prognosis. One of MIBC features is the nuclear atypia. However, the molecular mechanism underlying MIBC remains unclear.

View Article and Find Full Text PDF

Exploration of molecular markers is an ongoing focus in the field of bladder cancer research. Based on data from public databases, was identified as upregulated in bladder urothelial carcinoma (BLCA); however, its exact function and regulatory mechanism in this context remain unclear. To investigate the clinical implications of , we examined its levels in 90 BLCA and adjoining normal tissue samples.

View Article and Find Full Text PDF

Feasible approaches for arsenic speciation analysis in foods for dietary exposure assessment: a review.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess

January 2025

Department of Food Science and Nutrition, Hong Kong Polytechnic University, Kowloon, Hong Kong, China.

Arsenic (As) occurs naturally in different forms and oxidation states. Amongst them, inorganic arsenic (iAs) is classified as both genotoxic and carcinogenic whilst other organic arsenic species are considered less toxic. As in rice is mainly present in the form of iAs which therefore poses a health risk to populations that consume rice as a staple food.

View Article and Find Full Text PDF

Introduction: Approximately 75% of bladder cancer cases are non-muscle invasive at diagnosis. Drug development for non-muscle invasive bladder cancer (NMIBC) has historically lagged behind that of other malignancies. No treatment has demonstrated the ability to overcome drug resistance that ultimately leads to recurrence and progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!